| |
UAE
|
eGFR
|
|---|
|
OR (95% CI)
|
p values
|
OR (95% CI)
|
p values
|
|---|
|
Plaques
|
|
Model 1
|
1.22 (1.11–1.35)
|
< 0.001
|
0.49 (0.44–0.54)
|
< 0.001
|
|
Model 2
|
1.16 (1.03–1.30)
|
0.017
|
0.90 (0.79–1.02)
|
0.098
|
|
Model 3
|
1.19 (1.05–1.35)
|
0.007
|
0.88 (0.77–1.01)
|
0.059
|
|
Model 4
|
1.15 (1.00–1.32)
|
0.046
|
0.88 (0.76–1.02)
|
0.079
|
|
Model 5
|
1.20 (1.03–1.39)
|
0.020
|
0.88 (0.75–1.02)
|
0.089
|
|
Stenosis
|
|
Model 1
|
1.30 (1.17–1.45)
|
< 0.001
|
0.61 (0.54–0.68)
|
< 0.001
|
|
Model 2
|
1.27 (1.13–1.43)
|
< 0.001
|
1.04 (0.91–1.18)
|
0.614
|
|
Model 3
|
1.26 (1.11–1.42)
|
< 0.001
|
1.04 (0.91–1.19)
|
0.593
|
|
Model 4
|
1.22 (1.07–1.39)
|
0.003
|
1.08 (0.93–1.25)
|
0.312
|
|
Model 5
|
1.17 (1.01–1.35)
|
0.036
|
1.12 (0.95–1.31)
|
0.177
|
- UAE urinary albumin excretion, eGFR estimated glomerular filtration rate, DD duration of diabetes, APA anti-platelet agents, LLD lipid-lowering drugs, AHA anti-hypertensive agents, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, WHR waist-to-hip ratio, BMI body mass index, FPG fasting plasma glucose, 2-h PPG 2-h postprandial plasma glucose, HbA1c glycated hemoglobin A1c, FCP fasting C-peptide, 2-h PCP 2-h postprandial C-peptide, HOMA2-IR HOMA of insulin resistance, TG total triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ALT alanine transaminase, SUA serum uric acid
- Model 1: unadjusted
- Model 2: Adjusted for age, sex, DD, hypertension, smoking status and alcohol use
- Model 3: Further adjustment for use of AHA, LLD, APA
- Model 4: Further adjustment for SBP, DBP, BMI, WC and WHR
- Model 5: Further adjustment for ALT, TG, TC, HDL-C, LDL-C, SUA, FPG, 2-h PPG, HbA1c, FCP, 2-h PCP, HOMA2-IR
